Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Published: September 2011

Open Access Gateway

An Unusual Case of Locally Advanced Glycogen-Rich Clear Cell Carcinoma of the Breast

Martín-Martín B.a · Berná-Serna J.D.a · Sánchez-Henarejos P.b · López-Poveda M.J.c · Berná-Mestre J.D.a · Rodríguez-García J.R.d

Author affiliations

Departments of aRadiology, bOncology, cPathology and dObstetrics and Gynecology, Virgen de la Arrixaca University Hospital, Murcia, Spain

Corresponding Author

Dr. Juan de Dios Berná Serna

Department of Radiology Virgen de la Arrixaca University Hospital ES–30120 Murcia (Spain)

Tel. +34 968 369 596, E-Mail jdberna@gmail.com

Related Articles for ""

Case Rep Oncol 2011;4:452–457

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Glycogen-rich clear cell (GRCC) is a rare subtype of breast carcinoma characterized by carcinoma cells containing an optically clear cytoplasm and intracytoplasmic glycogen. We present the case of a 55-year-old woman with a palpable mass in the right breast and clinical signs of locally advanced breast cancer (LABC). The diagnosis of GRCC carcinoma was based on certain histopathological characteristics of the tumor and immunohistochemical analysis. To our knowledge, this is the first case of GRCC LABC with intratumoral calcifications. There is no evidence of recurrence or metastatic disease after 14 months’ follow-up.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: September 2011

Published online: September 07, 2011
Issue release date: September – December

Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 0

eISSN: 1662-6575 (Online)

For additional information: http://www.karger.com/CRO

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.